Search
Blog Post
Esophageal Cancer Q&A with Dr. Fountzilas
… Esophageal Cancer Q&A with Dr. Fountzilas April is Esophageal Cancer Awareness Month. Here, Christos Fountzilas, MD , Associate Professor of Oncology and …
News
Roswell Park Becomes Region’s Only NPF Center for Pancreatic Cancer
… access to state-of-the-art clinical trials,” adds Christos Fountzilas, MD , NPF Program Director at Roswell Park. “I … access to state-of-the-art clinical trials,” adds Christos Fountzilas, MD , NPF Program Director at Roswell Park. “I …
Blog Post
Can you have liver cancer and not know it?
… that is significantly damaged,” according to Christos Fountzilas, MD, FACP , Assistant Professor of GI Medical … fluke is a common cause of liver cancer, according to Dr. Fountzilas. More commonly, however, tumors or cancer in the …
Blog Post
New options for KRAS-associated cancers available at Roswell Park
… — or who develop resistance — to the drug,” says Christos Fountzilas, MD, FACP, Associate Professor of Oncology and … in my trial takes a different approach,” explains Dr. Fountzilas. “It binds to the KRAS molecule and breaks it …
Blog Post
What's New in Pancreatic Cancer Research?
… to treat it. “We should always have hope,” says Christos Fountzilas, MD, FACP , Department of Medical Oncology at … existing therapy. Some of the latest developments that Dr. Fountzilas considers exciting are new agents that target the …
News
Roswell Park Clinical Trials Add Beta Blocker to Arsenal Against Esophageal Cancer
… chemotherapy, and it becomes progressive.” Dr. Christos Fountzilas “Roswell Park is at the forefront of research on … and radiation in those patients,” says Christos Fountzilas, MD, FACP , Co-Leader of the Gastrointestinal …
Blog Post
Can a commonly prescribed blood pressure drug improve survival for patients with esophageal cancer?
… and radiation in those patients,” says Christos Fountzilas, MD, FACP , Co-Leader of the Gastrointestinal … Early Phase Clinical Trials Program at Roswell Park. Dr. Fountzilas was co-author of an article in the journal Lancet …
News
Roswell Park Study First to Show Two-Drug Combination Selectively Targets p53-Mutant Cancers
… in the United States,” notes study co-author Christos Fountzilas, MD, FACP , Co-Leader of the Gastrointestinal … Recognizing the need for better therapeutic options, Dr. Fountzilas and his colleague, Andrei V. Bakin, PhD , …
Blog Post
Burning questions about soothing acid reflux
… (NIHDDK) 11/28/2022 - 10:01 Esophageal Cancer Q&A with Dr. Fountzilas Gastroesophageal junction cancer: Rick's story …
Blog Post
Roswell Park Researchers Find Glucose Drives Growth of the Most Common Type of Esophageal Cancer
… To Reduce Your Cancer Risk Esophageal Cancer Q&A with Dr. Fountzilas Esophageal Cancer Research & News … A recent study …